Ligand validation:7OKU

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OKU_NAG_A_201	7%	63%	0.189	0.634	0.73	0.7	1	-	0	0	100%	0.9333
3JTC_NAG_B_600	96%	31%	0.058	0.965	1.2	1.55	1	7	0	0	100%	0.9333
1LQV_NAG_B_600	95%	67%	0.071	0.973	0.59	0.67	-	-	0	0	100%	0.9333
7OKV_NAG_A_201	70%	85%	0.111	0.927	0.25	0.48	-	-	0	0	100%	0.9333
7OKT_NAG_B_201	63%	65%	0.14	0.936	0.71	0.64	-	-	0	0	100%	0.9333
4V3D_NAG_B_205	55%	71%	0.138	0.906	0.4	0.71	-	1	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.